Imotopes: An immunotherapy animation of new immunotherapeutics

Nov 1, 2019 | Projects

ABOUT IMOTOPES

CLIENT: Imcyse is a clinical-stage biotech company created in 2010 as a spin-off of the Catholic University of Leuven, aiming to develop the next generation of therapeutic biologics.

SERVICE: At 3DforScience we turned the client illustrations into easily understandable 3D scientific animation explaining their disruptive approach through an immunotherapy animation.

Imcyse is developing a new class immunotherapeutic molecule: Imotopes. This new technology is the combination of target antigenic natural HLA-Class II peptidic epitopes with a specific thioredox motif.

As a result of this specific composition, the interaction between Imotopes and the antigen-specific T-cells induce lysis of a significant part of cells associated with the autoimmune response.

Therefore, these modified peptides successfully block the autoimmune response without affecting the other functions of the immune system. Thus, representing major progress for the treatment of autoimmune degenerative diseases such as type 1 diabetes, multiple sclerosis and rheumatoid arthritis.

How can 3DforScience help you?

3DforScience is a scientific communication company specialized in digital content for the pharma and biotech industries. Our passionate creative team works alongside an in-house scientific team to provide cutting-edge medical animations, scientific illustrations, virtual reality, etc.

Our extensive experience within the field ensures all the content we produce is scientifically accurate, innovative, engaging, and pitched at the right level for the target audience. Would you like to bring your scientific messaging to life? Contact us. We would love to help you create something unique.

ARE YOU INTERESTED IN SCIENTIFIC ANIMATION AND COMMUNICATION?

Related news

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio

Sappi is a global company focused on providing dissolving pulp, paper pulp, paper-based and biorefinery solutions to its customers in over 150 countries. They invest in research and development programs, unlocking the true potential of sustainable renewable resources,...

cPass™ technology by GenScript

cPass™ technology by GenScript

Coronaviruses are a large family of viruses that may cause illness in animals or humans.  In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS)...

B2B device: from breast to bone

B2B device: from breast to bone

ABOUT CLIENT: B2B is an EU-funded project that aims to develop a breakthrough technology that for the first time dissects the steps of spontaneous breast cancer metastasis to the bone and captures the 3D complexity of the process. The project started in July 2018,...